Human Recombinant IL-17A (from E. coli)

Supplier: Shenandoah Biotechnology
Ratings: (No Reviews)

Total Ratings: 0
Avg. Ratings: 0.0 out of 5

100-87-100UG 100-87-1MG 100-87-25UG 100-87-500UG 100-87-5UG
SHBT100-87-100UGEA 415 GBP
SHBT100-87-100UG SHBT100-87-1MG SHBT100-87-25UG SHBT100-87-500UG SHBT100-87-5UG
Human Recombinant IL-17A (from E. coli)
Proteins and Peptides

Interleukin 21 (IL-21) is a member of the common-gamma chain family of cytokines that are involved in immunoregulation. IL-21 is normally expressed by activated CD4+ T cells and is aberrantly expressed in Hodgkin lymphoma cells. The IL-21 receptor (IL-21R) activates the JAK/STAT signaling pathway and is expressed on T, B, and natural killer (NK) cells.


  • High quality
  • Low endotoxin
  • Affordable


Within the B cell lineage, IL-21 is a switch factor regulating IgG1 and IgG3 antibody production. IL-21 also cooperates with IL-4 for the production of multiple antibody classes in B cells. IL-21 has pleiotropic effects on the proliferation, differentiation, and effector functions of B, T, NK, and dendritic cells.


Elevated levels of IL-17A are associated with rheumatoid arthritis, airway inflammation, allograft rejection, inflammatory bowel disease, psoriasis, cancer, and multiple sclerosis. Human, mouse, and rat IL-17A show activity on mouse cells.


Delivery information: Certificate of analysis (COA) is supplied with each product shipped detailing purity, formulation, biological activity, endotoxin levels, reconstitution instructions and recommended storage conditions.


Caution: For research use only.

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR